Major Depressive Disorder

Study Shows Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients

Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients. …

Study Shows Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients Read More »

Monash University-Led Team Receives Funding for Psychedelic Psychotherapy in Treatment-Resistant Depression

The Medical Research Future Fund Clinical Trials Activity Initiative has awarded $2.7M for Innovative Therapies for Mental Illness to a Monash University-led team, to evaluate the efficacy of psilocybin-assisted psychotherapy in treatment-resistant depression. Major Depressive Disorder (MDD) is, sadly, common, and results in the greatest global burden of disease. Although there are established treatments for …

Monash University-Led Team Receives Funding for Psychedelic Psychotherapy in Treatment-Resistant Depression Read More »

Using Psychoactive Plants and Fungi for Long-Term Mental Wellness

By Raley Anne James According to a mental health organization, one in five adults in the U.S. experience having a mental illness each year. These include serious mental health conditions such as anxiety disorders, major depressive episodes, and post-traumatic stress disorder. Despite the various organizations trying to counter these issues to increase mental health awareness and …

Using Psychoactive Plants and Fungi for Long-Term Mental Wellness Read More »